0001415889-22-007913.txt : 20220722 0001415889-22-007913.hdr.sgml : 20220722 20220722162729 ACCESSION NUMBER: 0001415889-22-007913 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220712 FILED AS OF DATE: 20220722 DATE AS OF CHANGE: 20220722 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Willard Stephen H CENTRAL INDEX KEY: 0001325232 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38302 FILM NUMBER: 221100196 MAIL ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001719406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822844431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 484-254-6134 MAIL ADDRESS: STREET 1: 1201 ORANGE STREET STREET 2: SUITE 600 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp. DATE OF NAME CHANGE: 20171012 3 1 form3-07222022_010718.xml X0206 3 2022-07-12 0 0001719406 NRX Pharmaceuticals, Inc. NRXP 0001325232 Willard Stephen H C/O NRX PHARMACEUTICALS INC 1201 N. MARKET STREET, SUITE 111 WILMINGTON DE 19801 true true false false Chief Executive Officer Restricted Common Stock, par value $0.001 per share 1000000 D Grant of an inducement award of 1,000,000 restricted shares of the Company's common stock. The restricted shares will vest in approximately equal installments over three (3) years from July 12, 2022, subject generally to the reporting person's continued service to the Company through the applicable vesting date. /s/ Stephen Willard 2022-07-22